All announcements for “PHARMA”
Date | Category | Title | Ref |
---|---|---|---|
09/09/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-09092021-00006 |
06/09/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-06092021-00083 |
03/09/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-03092021-00011 |
30/08/2021 | Change in Audit Committee | Change in Audit Committee | C02-26082021-00018 |
27/08/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-27082021-00077 |
26/08/2021 | Change in Audit Committee | Change in Audit Committee | C02-26082021-00016 |
26/08/2021 | Change in Boardroom | Change in Boardroom | C03-26082021-00005 |
24/08/2021 | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) | CS2-24082021-00054 |
20/08/2021 | Financial Results | Quarterly rpt on consolidated results for the financial period ended 30 Jun 2021 | FRA-20082021-00042 |
20/08/2021 | Change in Boardroom | Change in Boardroom | C03-20082021-00005 |